Bio Pharma Dive
APRIL 14, 2022
Fresh trial results intensify competition with Roche to deliver the first lymphoma drug that marries antibody technology with an immunotherapy pathway.
World of DTC Marketing
APRIL 14, 2022
Over 70% of people have been exposed to medical or health-related misinformation. Of those exposed, almost half are not confident in their ability to discriminate between accurate health information and misinformation. Social media is cited as the most common source of misinformation. People on the right use social media to purposely hurt family members who lost loved ones to Covid.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioPharma Reporter
APRIL 14, 2022
Pfizer is set to acquire Australiaâs ResApp - a company developing a smartphone app to detect COVID-19 and other respiratory diseases based on the userâs cough - for $100m AUD ($74m USD).
pharmaphorum
APRIL 13, 2022
The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. It has now been 100 years since the first patient with diabetes received an injection of insulin, when Leonard Thomas, a 14-year-old boy, was treated with the hormone.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
APRIL 10, 2022
The slowdown has already forced many biotechs to wait longer to go public. There are early signs private financing deals may be flagging as well.
Pharma Mirror
APRIL 12, 2022
There are so many ways to get into the healthcare industry these days. There are a lot of changes happening in the industry which means that there are a lot of niche services that you can provide and make a lot of money while also serving your communities needs. For instance, telehealth is a burgeoning field these days and is a good place to start. Another area that has a lot of potentials is starting a medical lab facility.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Times
APRIL 13, 2022
Cantourage has appointed cannabis prescribers and is now officially operational via a new centre
Bio Pharma Dive
APRIL 14, 2022
A third shot sparked a strong immune response in clinical testing, positioning the companies to make boosters available to the roughly 28 million kids in the U.S. who became eligible for their first two doses late last year.
pharmaphorum
APRIL 12, 2022
The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category. The Department of Health, NHS England and NICE have completed an evaluation of two new antibiotics – Pfizer’s Zavicefta (ceftazidime/avibactam) and Shionogi’s Fetcroja (cefiderocol) – that will be paid for using the new subscription-like model likened to a Netflix account.
Intouch Solutions
APRIL 15, 2022
It’s officially Ramadan, the Islamic month where Muslims fast from sunrise to sunset. During this month, Muslims around the world will be taking time to reflect on their blessings, express gratitude, and give charity. With that said, Ramadan also poses some challenges for Muslims in the workplace. Here are some FYIs and tips on how to foster an inclusive environment for your Muslim employees or coworkers.
Pharma Times
APRIL 11, 2022
The biologics development and manufacturing facility is currently under construction near Oxford, UK
Bio Pharma Dive
APRIL 11, 2022
Pfizer is bringing in former Lowe's and CVS Health executive David Denton, while Moderna hired Jorge Gomez, previously CFO at Cardinal Health. Both take the reins as their new companies face strategic questions.
pharmaphorum
APRIL 11, 2022
Janssen’s Catherine Taylor, vice-president, EMEA medical affairs, therapy area strategy, discusses the importance of systemic innovation across the healthcare system to realise the full value of medicines. Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. As an oncology trained medical doctor who practiced in the UK NHS for 10 years, I have seen the benefits first-hand, as patients live longer lives, free from symp
XTalks
APRIL 14, 2022
Conventional in vitro and in vivo studies are used in the drug development pipeline. However, could there be another way for developing biomedical products using in silico technology? This involves the use of an individualized computer simulation for medical device or drug development. Therefore, companies can evaluate their drug candidates or medical device products in “virtual patients” before assessing them in humans.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
APRIL 11, 2022
Following successful appeals, the therapy has been recommended for all eligible bladder cancer patients
Bio Pharma Dive
APRIL 11, 2022
This year's meeting on early cancer research featured promising study results from German biotechs BioNTech and Affimed as well as details from a "practice-changing" lung cancer trial.
pharmaphorum
APRIL 11, 2022
In an interview with Dudley Tabakin (CEO, VivoSense), Chris Garabedian (CEO, Xontogeny) and Tanja Dowe (CEO, Debiopharm Innovation Fund), pharmaphorum discusses the recent announcement of the closing of a $25 million Series A financing round to scale up the innovative VivoSense® software, which uses wearable sensor data in clinical trials, and for the development of novel digital biomarkers.
XTalks
APRIL 13, 2022
There are over 300 million people worldwide who are living with a rare disease and around 75 percent of rare diseases will affect pediatric patients. Pediatric rare disease clinical trials are vital to determining the safety and efficacy of medications for children living with a rare disease. The World Health Organization (WHO) estimates that there are between 5,000 and 8,000 rare diseases worldwide.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Times
APRIL 12, 2022
Engetix and Takeda will extend existing agreement to collaborate extensively in the development of therapeutics in IBD
Bio Pharma Dive
APRIL 13, 2022
The British pharma is buying into the potential of a medicine meant to treat the anemia often associated with myelofibrosis, a complication that isn't adequately addressed by current therapies.
pharmaphorum
APRIL 13, 2022
GlaxoSmithKline has agreed a deal to buy Sierra Oncology and its lead drug momelotinib for anaemia associated with the blood cancer myelofibrosis, sending the US biotech’s shares skywards. GSK is paying $55 per share in cash for Sierra – a 39% premium to its closing share price yesterday – which values the company at around $1.9 billion. Shares in Sierra were up 38% in pre-market trading this morning.
NY Times
APRIL 11, 2022
The chemical derived from psychedelic mushrooms helped alleviate symptoms of depression and generated detectable neural responses that lasted weeks.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Times
APRIL 14, 2022
Approval demonstrates significant step forward in the treatment of adult advanced NSCLC patients with METex14
Bio Pharma Dive
APRIL 11, 2022
Leading through a pandemic is no easy feat but this pharmaceutical company's CEO led his organization not only from his head, but also from his heart.
pharmaphorum
APRIL 11, 2022
GripAble has raised $11 million in first-round financing that will be used to advance its digital health approach to rehabilitation for people with neurological and musculoskeletal conditions on the international stage. The London, UK-based company has developed a platform that combines a hand-held sensor, gamified mobile app software, and telehealth consultations with therapists, which is designed to entertain users while they train at home.
XTalks
APRIL 14, 2022
In this video, Xtalks spoke with Intertek Alchemy’s Laura Dunn Nelson, Vice President of Food Safety and Global Alliances. Laura spoke about her role at Intertek Alchemy and shared the most rewarding aspects of her work. Xtalks also asked Laura to discuss the challenges that companies are having today with their food safety culture. Laura has more than 30 years of experience implementing food safety and quality control programs for packaging, processing, retail operations and food service.
Pharma Times
APRIL 14, 2022
Trial of Amplivant will begin in a number of cancer patients including those with ovarian cancer
Bio Pharma Dive
APRIL 13, 2022
Cimeio Therapeutics, which emerged Wednesday with $50 million in funding, will use "shielding" technology to try to bring stem cell transplants and adoptive cell therapy to more patients.
pharmaphorum
APRIL 12, 2022
Cate Evans, SVP group director, strategy at Havas Media Group, and Nick Lapolla, research director at MedSurvey tell us about a two-phase research study the companies recently performed to understand a patient’s prescription journey and who influences prescription-based decisions. The healthcare landscape has shifted dramatically due to the pandemic.
Drug Patent Watch
APRIL 13, 2022
This chart shows the drugs with the most patents in Finland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Finland? appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Expert insights. Personalized for you.
361 
Let's personalize your content